542771 — Novateor Research Laboratories Cashflow Statement
0.000.00%
- IN₹198.81m
- IN₹204.35m
- IN₹38.28m
Annual cashflow statement for Novateor Research Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.28 | 0.395 | 0.463 | 1.13 | 1.14 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.342 | -4.73 | -4.56 | -4.04 | 5.71 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.2 | -6.22 | -6.48 | -9.01 | -10.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13.2 | -9.7 | -9.76 | -10.3 | -1.83 |
| Capital Expenditures | -15.1 | -3.56 | -7.36 | -6.96 | -0.184 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 4.9 | 4.84 | 4.75 | -4.85 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -15.1 | 1.34 | -2.52 | -2.22 | -5.04 |
| Financing Cash Flow Items | 1.42 | -0.192 | -0.257 | -0.712 | -0.858 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.49 | 5.8 | 11 | 14.3 | 8.89 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -24.8 | -2.56 | -1.3 | 1.77 | 2.02 |